Our results suggest that expanding of methylation in the promoter region of AXIN2 in SSAs lead to the suppression of the AXIN2 gene expression gradually, which contributes to a stepwise acquisition of the epigenetic features seen in MSI colon cancer. The gene discussed is AXIN2; the disease is colonic neoplasm.